Despite beating analyst expectations on both sales and EPS during the first quarter, St. Jude Medical Inc.'s earnings call this week left analysts with lingering questions regarding the company's pipeline and growth catalysts. St. Jude, of St. Paul, Minn., made $1.448 billion in sales during the quarter, which topped analysts' expectations by $10 million (consensus was $1.438 billion). The company's EPS also came in better than expected at 90 cents a share (consensus was 88 cents).